Gene: FHDC1
Official Full Name: FH2 domain containing 1provided by HGNC
Gene Summary: Predicted to enable actin binding activity and microtubule binding activity. Involved in Golgi ribbon formation; cilium assembly; and stress fiber assembly. Located in cilium and microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24193 | FHDC1 Knockout cell line (HeLa) | Human | FHDC1 | 1:3~1:6 | Negative | Online Inquiry |
KO24194 | FHDC1 Knockout cell line (HCT 116) | Human | FHDC1 | 1:2~1:4 | Negative | Online Inquiry |
FHDC1 Gene Knockout Cell Lines represent a pioneering advancement in cellular biology and genetics, specifically engineered to eliminate the FHDC1 gene function within the cellular framework. This gene encodes a protein implicated in various cellular processes, including cytoskeletal organization and cellular signaling pathways essential for cellular proliferation and differentiation. By meticulously knocking out the FHDC1 gene, these cell lines allow researchers to interrogate the physiological and pathological roles of FHDC1 in diverse biological contexts.
The mechanism by which FHDC1 Gene Knockout Cell Lines operate revolves around the precise ablation of the FHDC1 gene using targeted genome editing techniques such as CRISPR-Cas9. This process involves the introduction of double-stranded breaks at specific loci within the FHDC1 gene, facilitating its deletion or alteration, which in turn enables the evaluation of loss-of-function repercussions on cellular behavior and functionality.
These knockout cell lines hold significant scientific importance, serving as fundamental tools in research applications focusing on cancer biology, neurobiology, and developmental biology. They are crucial for understanding the intricate role of FHDC1 in disease mechanisms, gene regulation, and potential therapeutic targets. In clinical settings, insights gained from studies utilizing these cell lines can pave the way for novel treatment strategies and drug development.
Compared to alternative methods for studying gene function, such as transient transfection or RNA interference, FHDC1 Gene Knockout Cell Lines provide a stable and heritable model of gene disruption. This allows for consistent and reproducible results, minimizing variability often encountered in temporary gene silencing techniques. Additionally, these cell lines can be cultured over long periods, providing a sustainable resource for extensive experimental designs.
For researchers and clinicians alike, these knockout cell lines are invaluable as they facilitate a deeper understanding of gene function, ultimately leading to breakthroughs in therapeutic interventions and improved patient care. As a company dedicated to advancing biological research tools, we specialize in providing high-quality knockout cell lines that meet rigorous scientific standards, ensuring our customers can achieve their research goals with confidence and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.